CMS Names Six Vendors Participating in PQRI Pilot


By Maureen McKinney

May 6, 2008 | The Centers for Medicare and Medicaid Services (CMS) announced the six vendors that will participate in an upcoming pilot project using Physician Quality Reporting Initiative (PQRI) measures, which are extracted directly from electronic health record systems. The project is one of the requirements of the Medicare Physician Fee Schedule 2008, which mandated testing of PQRI measures using EHRs and also dictated the nomination process for vendors.

After CMS formally announced it was looking for partners in December 2007, interested companies volunteered by providing basic information such as their solutions’ security features and ability to segment out Medicare fee-for-service patients, said Brian Lancaster, director of physician strategy at Cerner.

Cerner is one of the participating vendors, along with eClinicalWorks, NextGen Healthcare Information Systems, DocSite, Allscripts, and Anceta.

According to Dr. Michael Rapp, director of the PQRI program at CMS, the purpose of the pilot is to see if utilizing data from EHRs will actually be a feasible method of collecting quality measures for the agency.

“The Physician Quality Reporting Initiative (PQRI) makes it possible for physicians and other eligible professionals to receive a financial incentive to report data on PQRI quality measures,” Rapp said in an email. “For 2007, professionals were only able to submit data using claims. For 2008, they can use both claims and registries to submit quality data. During 2008, we are testing the submission of quality data from Electronic Health Records, for possible future implementation.”

During the pilot project, vendors will submit data for five PQRI measures—three related to diabetes, one related to coronary artery disease, and one related to heart failure—to a CMS data warehouse for assessment. Cerner has partnered with long-time client, the University of Missouri, for the duration of the project and will use data from the medical center’s EHR.

Extracting quality from an electronic health record rather than from claims data holds several advantages, said Lancaster. The data capture is built directly into the workflow and physicians can act on the information as they see it, he explained. In addition, if EHR data proves to a be a viable source of quality measures, it could give Cerner an advantage in marketing to physicians who want higher levels of reimbursement as well as improved care.

“We’re hoping this boosts EHR adoption because it will be used for pay-for-performance and for providing quality care to patients,” Lancaster said. “Capturing that data during workflow will be a big feature for physicians.”

Hal Williamson, professor and chair of family and community medicine at the University of Missouri, agreed and said the university’s primary reason for collaborating with Cerner on this and past projects is the desire to steer away from using claims data for quality—a process he said requires multiple steps and must be done after care is administered.

“The extracting of information right out of medical record is direct, faster, and easier,” Williamson said. “Our physicians have really responded well to this, and we’ve heard a lot of ‘wows.’ Right now, the reality is just that CMS is trying to figure out if they can really do this.”

Data submissions for the pilot will end in September 2008, and at that time, CMS will assess the data and decide if they will allow future EHR-based submission of data for payment, the agency said.

Click here to log in.

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

White Papers & Special Reports

Next-Generation Technologies Revolutionizing Oncology and Diagnostics
underwritten by Definiens

This “Briefing On” collection of Bio-IT World features, commentaries and analysis, presents some of the latest thinking on high-throughput technologies that are being applied to the fields of research and drug discovery, with particular emphasis on oncology, diagnostics and imaging technologies. Download now at no charge compliments of the underwriting sponsor, Definiens. Download This Free Paper



This Bio•IT World Briefing On “Next-Generation Sequencing,” underwritten by GenomeQuest, Inc.,
presents a selection of feature stories, interviews,commentaries, conference reports, and editorials on the emergence, opportunities, and challenges posed by high-throughput sequencing. Covered in this collection: the launch of new platforms from Applied Biosystems and Helicos; new applications of nextgen sequencing; the rise of personal genomics; and informatics solutions to vexing problem of managing the vast volumes of next-gen data. Download now



MetaMiner™ Cystic Fibrosis Report
Sponsored by GeneGo

This paper discusses the MetaMiner™ (CF) data analysis platform for a broad range of CF researchers designed to:


1. Easily assemble important biological and chemical experimental data available today in cystic fibrosis research.
2. Visualize key mechanisms leading to the disease through pathway maps and network models.
3. Provide the CF community a “one stop shop” tool for uploading and analyzing experimental data in a disease-centered interface.
Download Now



Life Science Webcasts & Podcasts

GenoLogics
Enabling Translational Research Informatics

Learn about the challenges facing life sciences research labs to manage their translational research data:

  • The trends for organizations to adopt informatics solutions for translational research.
  • The unique requirements with managing complex data and workflow.
  • What labs should consider when reviewing informatics solutions for translational research.
  • Which life sciences research organizations are successfully adopting an informatics solution.

Download Now



More Podcasts

Job Openings

Isilon Systems ~ Senior Marketing Communications Manager
Isilon Systems is the worldwide leader in clustered storage systems and software for digital content and unstructured data. We seek an experienced marketing communications professional/writer expert in creating and delivering effective and persuasive business communications. The ideal candidate can think at the strategic and conceptual level and act, simultaneously, as a highly-effective and productive individual contributor. The position is based in Seattle, WA. For additional information click here:

Lilly Singapore Center for Drug Discovery (LSCDD) - Associate Director of Informatics
Lead and mentor a strong team for the Bioinformatics group at the Integrative Computational Sciences (ICS) department at LSCDD towards the development of novel algorithms, data analysis methods and software tools for drug discovery. Work closely with the Software Engineering group at ICS, and collaborate with the Discovery IT organization in Europe and USA. For additional information, or to apply visit: LSCDD

Related Resources & Products

Inflammatory Directions: Strategies for Six Diseases with Unmet Needs
Inflammatory Directions: Strategies for Six Diseases with Unmet Needs
Study Site Series Vol. 6 - Understanding, Evaluating and Implementing Clinical Protocols (1999)
Study Site Series Vol. 5 - Your Role in Reporting Adverse Experiences (1999)



For reprints and/or copyright permission, please contact RMS, 1808 Colonial Village Lane, Lancaster, PA;

(717) 399-1900 ext. 125 or via email to [email protected].